Wordt geladen...
Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases
Cardiometabolic diseases are characterized as a combination of multiple risk factors for cardiovascular disease (CVD) and metabolic diseases including diabetes mellitus and dyslipidemia. Cardiometabolic diseases are closely associated with cell glucose and lipid metabolism, inflammatory response and...
Bewaard in:
| Gepubliceerd in: | Front Pharmacol |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7479173/ https://ncbi.nlm.nih.gov/pubmed/32982723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.01247 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|